Home | Publications | Country | Europe (West) | Finland place holder
place holder place holder

Finland

The Pharmaceutical Market: Finland


Publication Date   January 2007
Publisher   Espicom
Product Type   Strategic Report
Pages   80
ISBN Number   not applicable
Product Code   ESP603
Ask a question about this product?

Price £595.00

approximately: $1,178 | €756

Summary


In 2006, the Finnish pharmaceutical market was estimated to be worth US$3.7 billion, equal to 23.4% of healthcare expenditure and 1.9% of estimated GDP. The market is equivalent in size to Argentina, yet is on a par with Switzerland in terms of per capita expenditure. Pharmaceutical per capita expenditure in 2006 is US$699.

The principal regulatory body in Finland is the National Agency for Medicines (NAM), operating under the Ministry for Social Affairs and Health. All pharmaceutical products, available on the domestic market and exported, must receive authorisation from NAM. NAM regulations stipulate conditions on the basis of quality, safety and effectiveness.

The principal authority regarding application for reimbursable status is the Pharmaceutical Pricing Board, affiliated to the Ministry of Social Affairs and Health. Other matters concerning reimbursable status are dealt with by the Social Insurance Institution (SII).

The NAM is viewed as a respected agency in the Mutual Recognition Procedure and is the leading agency in the EU as a reference state in the role of marketing authorisations.

The vast majority of imports are in the form of retail medicaments, accounting for 92.9% of the US$1.7 billion of pharmaceuticals imported from a wide range of countries in 2005. Pharmaceutical exports amounted to US$708 million, indicating that much of the market is import driven.

These in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.

Content


Background Data

  • Geography
  • Political Overview
  • Economic Overview
    • Estimated/Projected GDP 2004-2011
  • Population
    • Population, 1990-2005
    • Population by Region,
  • Demographic Indicators
    • Demographic Indicators, 1995-2005
  • Mortality
    • Registered Causes of Death, 2001-2005
  • Morbidity
    • Reported Incidence of Infectious Diseases,
    • Reported Cases of HIV & AIDS, and AIDS Related Deaths, 1995-2006
  • Charts
    • Map of Finland
    • Population by Age Group, 2005 (%)
    • Leading Causes of Death, 2005 (%)
    • Chichester, West Sussex, PO20 2FS, United Kingdom

Healthcare System

  • Organisation & Administration
  • Health Expenditure
    • Health Expenditure at Current Prices, 1985-2004 (million euros)
    • Health Expenditure by Category, 1998-2004 (million euros)
    • Outpatient Expenditure by Category, 1994-2000 (million euros)
  • Hospital Services
    • Hospitals by Type, 1998
    • Hospital Beds,
    • Hospital Activity
    • Inpatient Activity Summary,
    • Average Length of Stay by Healthcare Provision, 2003 (days)
    • Average Length of Stay by Hospital Type,
    • Average Length of Stay by Speciality, 1995-2003
    • Inpatient Primary Healthcare Patient Numbers,
    • Inpatient Primary Healthcare Patient Days by Significant Disease Groups, 1997-2003
    • Inpatient Specialised Healthcare Patient Numbers,
    • Inpatient Specialised Healthcare Patient Days, 1997-2003
    • Average Length of Stay in Specialised Healthcare by Disease Classification, 1997-2003 (Days)
    • Hospital Procedures
    • Patient Numbers for Common Operations and Procedures, 1997-2003
    • Care Days for Operations and Procedures, 1997-2003
    • Average Length of Stay for Common Operations and Procedures, 1997-2003 (days)
  • Ambulatory Care
    • Outpatient Visits to Health Centres by Type of Activity,
    • Outpatient Visits to Specialist Outpatient Centres by Specialty, 1999-2003
    • Dental Visits, 1997-2003
  • Medical Personnel
    • Healthcare Professionals of Working Age,
    • Healthcare Professionals of Working Age,
    • Physicians of Working Age by specialty, 2004
  • Finland Healthcare System
  • Charts
    • Health Expenditure by Category, 2004 (%)
    • Health Expenditure, 1985-2004
    • Total Admissions and ALOS, 1990-2004
    • Chichester, West Sussex, PO20 2FS, United Kingdom
  • Accessing The Pharmaceutical
  • Market

Accessing The Pharmaceutical Market

  • Introduction
  • Regulatory Environment
    • European Union Regulatory Reforms
    • Centralised Procedure
    • The EMEA
    • Mutual Recognition Procedure
    • Pharmaceutical Registration
    • Advertising
    • Patent Protection & Intellectual Property Rights
    • Supplementary Protection Certificates
    • Pricing and Reimbursement
    • Reimbursement
    • Drug Price Structure
  • Distribution Channels
    • Pharmacies, 1980-2005
    • Distributors
  • Domestic Production
    • Summary of Domestic Production, 2000-2005 (euro thousands)
    • Summary of Manufacturing Facilities and Employees, 2000-2005
    • Trade Associations
    • PIF member companies, 2006
    • Domestic Producers
    • Research & Development
  • Directory
  • Charts
    • Average Drug Price Structure,